The Joint Corp. (NASDAQ: JYNT) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $91M. The Maz Rating grades it against the other companies in its sector.
The Joint Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.65, The Joint Corp. trades at 33.5x trailing earnings, 1.6x sales and 7.7x book value, with an EV/EBITDA of 15.6. Over the last twelve months it generated about $58M of revenue and $3M of net income. It runs a gross margin of 81.6%, an operating margin of 4.4% and a net margin of 4.8%. It shows return on equity of 19.3%, return on invested capital of 10.6% and a free cash flow yield of 2.5%. On the balance sheet: a debt-to-equity ratio of 0.16 and a current ratio of 1.96. Over the past 52 weeks the share price ranged from $6.52 to $10.67, with a beta of 1.16.
The Joint Corp. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 4 Buy and 4 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.